Shares of Meeka Metals (ASX:MEK) have fallen by as much as 8.7% to A$0.042, marking their lowest level since August 4.

The gold and rare earth company announced it has received firm commitments to raise A$3.5 million ($2.25 million).

The issue price of A$0.04 per share is at a 13% discount compared to the closing price on September 27.

Meeka Metals said that the funds raised will be utilized for exploration and in-fill drilling at the Murchison Gold Project, among others.

As of the last close, MEK stock has fallen 32.4% YTD.

Meeka Metals (ASX:MEK) is a gold and rare earth company with projects in Australia.

Coronado Global Resources (ASX:CRN) has amended its forecasts for the balance of 2023.

Mining activities at the Buchanan mine were temporarily impacted by geological conditions in the coal seam during the September quarter.

Efforts are being made to recover these lost tons in the final quarter of 2023 and the first quarter of 2024.

In mid-September, there was a mechanical failure in the propel unit of one of the draglines at Curragh.

Production from Curragh will be impacted in FY23 due to the ensuing delay in waste removal.

Average mining costs per tonne sold for FY23 have been revised to be between US$97.0 - US$102.0.

Repairs at Curragh are already underway and expected to be finished by the end of October.

The revised FY23 guidance for saleable production is between 16.2 MT - 16.4 MT.

The company does not predict a significant cash impact in FY23.

The revised FY23 guidance for capital expenditure is $220 million - $240 million.

They also expect to see further support for increasing metallurgical coal pricing for the remainder of 2023 and into 2024.

Coronado Global Resources is a company involved in mining and the production of coal.

VEEM (ASX:VEE) shares experienced a significant increase of as much as 21.4% to A$0.680.

This marks the company’s highest intraday percent gain since May 24, 2022.

VEEM, a producer of marine propulsion and stabilization systems, announced that it has entered into agreements with Sharrow Engineering.

The deal enables VEEM and Sharrow to collaborate on the design and exclusive manufacture of Sharrow-designed propellers for inboard powered vessels, offering these products worldwide.

Design work is already underway, and the first shipment of SHARROW by VEEM propellers is anticipated to available in early 2024.

VEEM’s shares recently achieved their highest level since September 8, and the stock has risen 1.8% year-to-date.

VEEM is a marine technology company specializing in the design and manufacture of propulsion and stabilization systems for the global marine market.

Shares of the Australian health-tech company Careteq saw a considerable leap of up to 18.2% to A$0.026, marking their highest point since September 15.

The increase sets the stage for their top day since September 11, provided the gains maintain.

Careteq announced the receipt of a 1,500-unit TEQ-Secure order from ADT New Zealand.

ADT New Zealand is a subsidiary of the Intelligent Monitoring Group.

TEQ-Secure is a personal safety pendant designed to ensure user safety, particularly for those working in the field.

Deliveries are scheduled to commence in early November, with addition to the platform expected in the following weeks.

Despite the recent spike, the stock has seen a 60.6% decrease this year, as of the last close.

Careteq is a health-tech company that specializes in personal safety products.

Shares of Syrah Resources (ASX:SYR) witnessed a rise of as much as 13.7% to A$0.580, reaching their highest level since eighteen September.

The stock was last recorded up 11.8%.

The diversified miner clarified a media article dated October 1 that stated they continue to mine and stockpile, rather than sell output.

The company further clarified that the production campaign has been carried out at its Balama Graphite Operation at a southern African offshore mine.

Syrah Resources added that the sales and shipments of natural graphite were completed during the September 2023 quarter.

Despite the current rise, the stock has witnessed a fall of 75.2% this year, as per the latest data.

Syrah Resources is a materials company that specializes in mining and producing graphite.

PolyNovo (ASX:PNV) shares increment by nearly 2.7% to A$1.34, marking their highest value since Sept.

As stated by the medical devices company, it has secured an additional $10 million from the Biomedical Advanced Research and Development Authority (BARDA).

This additional funding aids the company’s impactful trial program of NovoSorb BTM, made for the treatment of full-thickness burns.

PolyNovo (ASX:PNV) announced that this additional funding brings the total BARDA commitment up to $25 million.

Despite this, the stocks of the company have gone down 35.4% YTD, noted at the most recent closing.

PolyNovo is a medical device company that focuses on the design, development and manufacture of innovative medical devices using its patented NovoSorb biodegradable polymer technology.

Coronado Global Resources (ASX:CRN) shares dipped by an approximate 5.9% to A$1.830, marking potentially its worst day since August 8, provided the losses persist.

The coal producer updated its guidance for the remainder of 2023, citing adverse operating conditions at its Buchanan mine and unexpected repair downtime at the Curragh mining complex.

Coronado adjusted its FY23 saleable production projection to between 16.2 metric tons and 16.4 metric tons, down from the previous range of 16.8 metric tons to 17.2 metric tons.

Associated mining costs per ton sold for FY23 are now predicted to fall between $97 million and $102 million, an increase from the former $84 million to $102 million.

As of the last close, the stock was down 2.3% YTD, reaching its lowest level since September 26.

Coronado Global Resources (ASX: CRN) is a leading producer of coal with multiple mining complexes.

Shares of Galileo Mining (ASX:GAL) have seen a significant increase, rising as much as 18.6% to A$0.350 and reaching their highest value since the 6th of September.

The stock is currently up by approximately 17%, making it on track for its best day since June 9.

This surge follows the specialty mining company’s announcement of the discovery of high-grade ores for gold, nickel, and copper at its onshore mine location in Western Australia.

Today, 350,749 shares have changed hands, which is 1.2 times the 30-day average volume of 287,388 shares.

Notably, despite today’s gains, the stock has fallen by 65.6% this year as of its last close.

Galileo Mining is a specialty mining company focused on the exploration and development of gold, nickel, and copper ores.

Cyclopharm (ASX:CYC) shares experienced an 11.3% surge, elevating its market value to A$3.150 - a peak not witnessed since January 28, 2021.

The healthcare company, specializing in medical equipment and technology, announced that it has procured a coveted approval from the US Food and Drug Administration to initiate commercial sales of Technegas in America.

Technegas is a diagnostic tool used in the management of pulmonary embolism or, as it’s more colloquially known, lung artery blockage.

The company’s shares were traded 172,232 times, which is 5.4 times their average 30-day trade volume of 32,360.

An impressive performance given the company’s stock has more than doubled its value so far this year.

Cyclopharm (ASX:CYC) is a medical equipment and technology provider recognized for its revolutionary contribution in pulmonary care.

Morgan Stanley has lowered the price target for Australia’s Westpac Banking Corp (ASX:WBC) due to perceived ‘challenges’ in its turnaround strategy.

The brokerage has decreased the price target by 2.5% to A$20.10, while maintaining an ‘Equal-weight’ rating on the lender.

Morgan Stanley stated, ‘There are some signs of improvement in Westpac’s franchise performance, but competition and inflation have made the turnaround more challenging.’ The firm anticipates lagging revenue growth for Westpac compared to its major bank peers in the three years to FY25, and an even more uncertain outlook for cost growth.

It also downgraded the bank’s profit excluding notable items by 2% in FY24 and 3% in FY25E due to higher expenses.

Westpac’s stock is currently down 0.4% at A$21.065.

Out of 13 analysts, three rate the stock as ‘buy’, four ‘hold’, and six ‘sell’ or lower, with a median price target of A$20.80.

As of the last close, the stock was down 9.4% for the year.

Westpac Banking Corp (ASX:WBC) is one of Australia’s largest banks and provides a broad range of banking and financial services.